These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8136046)

  • 1. The interplay of learning and anxiety in the elevated plus-maze.
    File SE
    Behav Brain Res; 1993 Dec; 58(1-2):199-202. PubMed ID: 8136046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze.
    File SE; Mabbutt PS; Hitchcott PK
    Psychopharmacology (Berl); 1990; 102(1):98-101. PubMed ID: 1975449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?
    File SE; Zangrossi H
    Psychopharmacology (Berl); 1993; 110(1-2):240-4. PubMed ID: 7870892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial 2 in the elevated plus-maze: a different form of fear?
    File SE; Zangrossi H; Viana M; Graeff FG
    Psychopharmacology (Berl); 1993; 111(4):491-4. PubMed ID: 7870992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
    Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure.
    Frussa-Filho R; Ribeiro Rde A
    Life Sci; 2002 Jun; 71(5):519-25. PubMed ID: 12052436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine.
    Ouagazzal AM; Kenny PJ; File SE
    Psychopharmacology (Berl); 1999 May; 144(1):54-60. PubMed ID: 10379624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze.
    Stern CA; Carobrez AP; Bertoglio LJ
    Pharmacol Biochem Behav; 2008 Oct; 90(4):545-50. PubMed ID: 18533241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of open arm ledges and maze experience in the elevated plus-maze.
    Fernandes C; File SE
    Pharmacol Biochem Behav; 1996 May; 54(1):31-40. PubMed ID: 8728536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze test is abolished by previous administration of chlordiazepoxide or buspirone.
    Escarabajal MD; Torres C; Flaherty CF
    Life Sci; 2003 Jul; 73(8):1063-74. PubMed ID: 12818358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity.
    Albrechet-Souza L; Borelli KG; Carvalho MC; Brandão ML
    Neuroscience; 2009 Dec; 164(2):387-97. PubMed ID: 19699782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats.
    Bertoglio LJ; Carobrez AP
    Psychopharmacology (Berl); 2003 Dec; 170(4):335-42. PubMed ID: 13680083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety.
    Bertoglio LJ; Carobrez AP
    Behav Brain Res; 2000 Mar; 108(2):197-203. PubMed ID: 10701663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal ethanol effects on benzodiazepine sensitivity measured by behavior on the elevated plus-maze.
    Osborn JA; Yu C; Gabriel K; Weinberg J
    Pharmacol Biochem Behav; 1998 Jul; 60(3):625-33. PubMed ID: 9678645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze.
    Korte SM; De Boer SF
    Eur J Pharmacol; 2003 Feb; 463(1-3):163-75. PubMed ID: 12600708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body exposure to 2.45 GHz electromagnetic fields does not alter anxiety responses in rats: a plus-maze study including test validation.
    Cosquer B; Galani R; Kuster N; Cassel JC
    Behav Brain Res; 2005 Jan; 156(1):65-74. PubMed ID: 15474651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze.
    Bertoglio LJ; Carobrez AP
    Pharmacol Biochem Behav; 2002 Nov; 73(4):963-9. PubMed ID: 12213543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze.
    Bertoglio LJ; Carobrez AP
    Pharmacol Biochem Behav; 2002 May; 72(1-2):449-55. PubMed ID: 11900819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation.
    Pereira JK; Vieira RJ; Konishi CT; Ribeiro RA; Frussa-Filho R
    Life Sci; 1999; 65(10):PL101-7. PubMed ID: 10499876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.